CD19, CD19 molecule, 930

N. diseases: 365; N. variants: 5
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs2904880
rs2904880
Entrez Id: 930;79874
Gene Symbol: CD19;RABEP2
CD19;RABEP2
CUI: C0021704
Disease:
Intelligence 		C 0.700 GeneticVariation GWASCAT A combined analysis of genetically correlated traits identifies 187 loci and a role for neurogenesis and myelination in intelligence. 29326435 2019
dbSNP: rs2904880
rs2904880
Entrez Id: 930;79874
Gene Symbol: CD19;RABEP2
CD19;RABEP2
CUI: C1305855
Disease:
Body mass index 		C 0.700 GeneticVariation GWASCAT Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. 29273807 2018
dbSNP: rs2904880
rs2904880
Entrez Id: 930;79874
Gene Symbol: CD19;RABEP2
CD19;RABEP2
CUI: C0005893
Disease:
Body mass index procedure 		0.700 GeneticVariation GWASDB Gene-centric meta-analyses of 108 912 individuals confirm known body mass index loci and reveal three novel signals. 23001569 2013
dbSNP: rs2904880
rs2904880
Entrez Id: 930;79874
Gene Symbol: CD19;RABEP2
CD19;RABEP2
CUI: C0578022
Disease:
Finding of body mass index 		0.700 GeneticVariation GWASDB Gene-centric meta-analyses of 108 912 individuals confirm known body mass index loci and reveal three novel signals. 23001569 2013
dbSNP: rs1567506566
rs1567506566
Entrez Id: 930;79874
Gene Symbol: CD19;RABEP2
CD19;RABEP2
CUI: C3150738
Disease:
Antibody Deficiency due to Defect in CD19 		T 0.700 CausalMutation CLINVAR
dbSNP: rs886037920
rs886037920
Entrez Id: 930;79874
Gene Symbol: CD19;RABEP2
CD19;RABEP2
CUI: C3150738
Disease:
Antibody Deficiency due to Defect in CD19 		C 0.700 CausalMutation CLINVAR
dbSNP: rs886037921
rs886037921
Entrez Id: 930
Gene Symbol: CD19
CD19
CUI: C3150738
Disease:
Antibody Deficiency due to Defect in CD19 		A 0.700 CausalMutation CLINVAR
dbSNP: rs2904880
rs2904880
Entrez Id: 930;79874
Gene Symbol: CD19;RABEP2
CD19;RABEP2
CUI: C0036421
Disease:
Systemic Scleroderma 		0.010 GeneticVariation BEFREE Among the whole SSc population, 304 (34%) had the diffuse cutaneous subtype, 551 (61%) had the limited cutaneous subtype, 732 (81%) were positive for antinuclear antibodies , 331 (37%) were positive for anticentromere antibodies and 228 (25%) for the topo-isomerase I. Genotyping has been performed for CD19 rs35979293, CD19 rs2904880, CD20 rs7126354, CD20 rs3802954, CD20 rs105146, CD20 rs4939364, CD22 rs10406069, CD22 rs10413500, CD22 rs10419538, CD22 rs34826052 and CD24 ins-del polymorphisms. 21961844 2012
dbSNP: rs35979293
rs35979293
Entrez Id: 930;79874
Gene Symbol: CD19;RABEP2
CD19;RABEP2
CUI: C0036421
Disease:
Systemic Scleroderma 		0.010 GeneticVariation BEFREE Among the whole SSc population, 304 (34%) had the diffuse cutaneous subtype, 551 (61%) had the limited cutaneous subtype, 732 (81%) were positive for antinuclear antibodies , 331 (37%) were positive for anticentromere antibodies and 228 (25%) for the topo-isomerase I. Genotyping has been performed for CD19 rs35979293, CD19 rs2904880, CD20 rs7126354, CD20 rs3802954, CD20 rs105146, CD20 rs4939364, CD22 rs10406069, CD22 rs10413500, CD22 rs10419538, CD22 rs34826052 and CD24 ins-del polymorphisms. 21961844 2012
dbSNP: rs35979293
rs35979293
Entrez Id: 930;79874
Gene Symbol: CD19;RABEP2
CD19;RABEP2
CUI: C0024141
Disease:
Lupus Erythematosus, Systemic 		0.010 GeneticVariation BEFREE Two SNPs, c.705G>T (P235P and IVS14-30C>T, were decreased (P = 0.0096 and P = 0.028, respectively), in SLE. 12215898 2002